These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27413355)

  • 1. An evaluation of drug promotional literatures published in scientific medical journals.
    Vachhani PM; Solanki MN; Desai MK
    J Pharm Bioallied Sci; 2016; 8(3):248-52. PubMed ID: 27413355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Critical Review of the Drug Promotional Literature Published in Scientific Medical Journals and Available at Outpatient Departments: A Cross-Sectional Observational Study.
    Vivek K; Deolekar P; Naseem A; Langade DG; Yadav P
    Cureus; 2022 Nov; 14(11):e31283. PubMed ID: 36514598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical Appraisal of Drug Promotional Literature in Accordance With WHO Guidelines.
    Rode SB; Salankar HV; Katole NT; Deshkar AT; Dadmal AA; Parate SV
    Cureus; 2022 Aug; 14(8):e27644. PubMed ID: 36072198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical review of drug promotional literature using the World Health Organization guidelines.
    Ganashree P; Bhuvana K; Sarala N
    J Res Pharm Pract; 2016; 5(3):162-5. PubMed ID: 27512705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to WHO Criteria on Drug Promotion Literature: An Exploratory Study From a Tertiary Healthcare Facility in South-West Nigeria.
    Fadare JO; Bankole I; Babatola A; Simeon Olatunya O; Aina F; Godman B
    Hosp Pharm; 2023 Feb; 58(1):62-69. PubMed ID: 36644744
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug advertisements in two dermatology journals: a critical comparison of IJDVL and JAAD.
    Gahalaut P; Chauhan S; Mishra N; Rastogi M; Thakur R
    Indian J Dermatol Venereol Leprol; 2014; 80(2):115-21. PubMed ID: 24685846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence of Drug Promotional Literatures Distributed by Pharmaceutical Companies to World Health Organization Ethical Criteria for Medicinal Drug Promotion.
    Prasad P; Bajracharya SR; Deo S; Lamichhane S; Pradhan PMS; Ghimire R; Pokharel A
    J Nepal Health Res Counc; 2019 Nov; 17(3):345-350. PubMed ID: 31735930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug advertisements published in Indian Medical Journals: Are they ethical?
    Charan J; Yadav P; Saxena D; Kantharia ND
    J Pharm Bioallied Sci; 2011 Jul; 3(3):403-6. PubMed ID: 21966161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of promotional advertisements of drugs in a medical journal: an ethics perspective.
    Nath S; Bhowmick S; Dutta T; Chowrasia VR; Bhattacharya S; Chatterjee RN; Sarkar M; Ram AK; Mukherjee PK
    Indian J Med Ethics; 2014; 11(4):237-41. PubMed ID: 25377037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of rationality of promotional drug literature using World Health Organization guidelines.
    Mali SN; Dudhgaonkar S; Bachewar NP
    Indian J Pharmacol; 2010 Oct; 42(5):267-72. PubMed ID: 21206615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survey of instructions to authors in Indian and British Dental Journals with respect to ethical guidelines.
    Mathur VP; Dhillon JK; Kalra G; Sharma A; Mathur R
    J Indian Soc Pedod Prev Dent; 2013; 31(2):107-12. PubMed ID: 23886722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethical Process Reporting in Indian Dental Journals.
    Janakiram C; Porteri C
    Account Res; 2016; 23(3):163-177. PubMed ID: 26453084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial policy and the reporting of randomized controlled trials: a survey of instructions for authors and assessment of trial reports in Indian medical journals (2004-05).
    Tharyan P; Premkumar TS; Mathew V; Barnabas JP; Manuelraj
    Natl Med J India; 2008; 21(2):62-8. PubMed ID: 18807310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescribers Perception on Drug Promotional Literatures in A Tertiary Care Hospital in Nepal.
    Prasad P; Mudvari A; Ghimire R; Karki N; Yadav D; Shah S; Gyanwali P
    J Nepal Health Res Counc; 2021 Apr; 19(1):19-25. PubMed ID: 33934127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scientific basis of the OCRA method for risk assessment of biomechanical overload of upper limb, as preferred method in ISO standards on biomechanical risk factors.
    Colombini D; Occhipinti E
    Scand J Work Environ Health; 2018 Jul; 44(4):436-438. PubMed ID: 29961081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supported and unsupported claims in medicinal drug advertisements in Indian medical journals.
    Dhanaraj E; Nigam A; Bagani S; Singh H; Tiwari P
    Indian J Med Ethics; 2011; 8(3):170-4. PubMed ID: 22106646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Authorship criteria and reporting of ethical compliance in Indian biomedical journals.
    Bolshete P
    Indian J Med Ethics; 2017; 2(3):160-164. PubMed ID: 28214788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the degree of compliance of Spanish scientific biomedical journals with international standards of presentation of periodicals].
    Delgado López-Cózar E
    Rev Esp Salud Publica; 1997; 71(6):531-46. PubMed ID: 9477708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceptions of and barriers to ethical promotion of pharmaceuticals in Pakistan: perspectives of medical representatives and doctors.
    Gul R; Saeed H; Saleem Z; Rasool F; Hashmi FK; Islam M; Imran I; Raza SA; Danish Z
    BMC Med Ethics; 2021 Jan; 22(1):2. PubMed ID: 33397339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of drug promotional materials in a hospital setting in Nepal.
    Alam K; Shah AK; Ojha P; Palaian S; Shankar PR
    South Med Rev; 2009 Apr; 2(1):2-6. PubMed ID: 23093870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.